20 GENDER DIVERSITY.Cdr
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Research Paper IJMSRR Impact Factor 0.348 E- ISSN - 2349-6746 ISSN -2349-6738
Research Paper IJMSRR Impact Factor 0.348 E- ISSN - 2349-6746 ISSN -2349-6738 A STUDY ON PERFORMANCE OF MAJOR IT COMPANIES OF INDIA Prof. (Dr). C.K.Madhusoodhanan Professor, Dept. of Management Studies, Sree Narayana Gurukulam College of Engineering, Kolenchery Kerala. A.V Rejimon Assistant Professor, Dept. of Management Studies, Sree Narayana Gurukulam College of Engineering, Kolenchery, Kerala. Introduction Globalisation, liberation and privatisation were initiated by the Narsimha Rao government in early nineties. The new economic policy of the government of India generated industrial growth. It led to unprecedented development of industries. I T industry became one of the most flourishing industries in India. The investment in I T Sector has increased since India opened up the economy for private sector. Emergence of Globalised economy witnessed growth of I T industry. Many new cooperates entered the industry. Different types of investors showed keen interest in investing in I T stocks because of the higher rate of return. In portfolio selection the investors are confronted with an issue of identifying the right company having intrinsic value for the investment. The issue to be discussed with is how to select the right company in the context of mushroom growth of IT companies with plenty of new entrance with little history but with great volume of profit. Literature Review The origin of Fundamental analysis for the share price valuation can be dated back to Graham and Dodd (1934) in which the authors have argued the importance of the fundamental factors in share price valuation. Theoretically, the value of a company, hence its share price, is the sum of the present value of future cash flows discounted by the risk adjusted discount rate. -
India: Inventory of Estimated Budgetary Support and Tax Expenditures for Fossil-Fuels
INDIA: INVENTORY OF ESTIMATED BUDGETARY SUPPORT AND TAX EXPENDITURES FOR FOSSIL-FUELS Energy resources and market structure India is one of the fastest growing energy markets in the world. The country is the world’s third largest coal producer owing to its large deposits. Coal is the leading primary fuel in India’s energy mix, accounting for 44% of the country’s total primary energy supply (TPES), with thermal power plants making up the majority of coal consumption. Biomass accounts for 25% of total energy use, followed by oil and natural gas, which account respectively for 22% and 7% of the country’s energy needs. Remaining energy sources, such as nuclear power and hydro-electricity, account for about 1% each. The country’s proven reserves of oil were 5.5 billion barrels as of December 2012; nonetheless, domestic production falls far short of domestic demand and the country depends heavily on imported crude oil. The state-owned coal company, Coal India Limited (CIL), retains a near monopoly of coal extraction, with over 90% of domestic coal extraction attributed to government-controlled mines. Most coal mining occurs in the states of Bihar, Chhattisgarh, Jharkhand, Madhya Pradesh, Orissa, and West Bengal. Market reforms are being implemented to bring competition and transparency to the coal sector. The government has been grappling to get an effective regulatory framework in place, which includes the loosening of regulations for the coal industry, with the objective of moving some grades of coal closer to international market prices, and allocating additional coal blocks through a transparent open bidding process. -
Investor Presentation May 2016
Investor Presentation May 2016 BSE: 532523 │ NSE: BIOCON │ REUTERS: BION.NS │ BLOOMBERG: BIOS IN │ WWW.BIOCON.COM Safe Harbor Certain statements in this release concerning our future growth prospects are forward-looking statements, which are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those contemplated in such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, amongst others general economic and business conditions in India, our ability to successfully implement our strategy, our research and development efforts, our growth and expansion plans and technological changes, changes in the value of the Rupee and other currencies, changes in the Indian and international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian biotechnology and pharmaceuticals industries, changes in political conditions in India and changes in the foreign exchange control regulations in India. Neither the company, nor its directors and any of the affiliates have any obligation to update or otherwise revise any statements reflecting circumstances arising after this date or to reflect the occurrence of underlying events, even if the underlying assumptions do not come to fruition. 2 Agenda Biocon: Who are we? Highlights • Business Highlights • Financial Highlights Growth Segments • -
Most Market Roundup.Pmd
MOSt Market Roundup 1st March 2019 EQUITY Market Sensex 36063.81 196.37 Nifty 10863.50 71.00 Cash Volumes (INR in Crores) Dealer's Diary Exchange Today Pev. Day Markets bounced back after falling for 3 trading sessions. Nifty climbed BSE (Cash) - 2,082 0.66% or 71 pts to close at 10863. Rally in the global markets and reduced NSE (Cash) 31,263 42,766 geo-political tensions, boosted the market sentiments. Moreover, Feb NSE(Derivatives) 4,05,084 17,00,963 mfg PMI which came at a 14-month high at 54.3, fall in USDINR and 10- Year G-Sec yield, also helped. China (up 1.5%), Nikkei and Hong Index Advance / Decline gained smartly, European markets advanced half to one percent and Group NIFTY 50 BSE 200 US Futures gained over half a percent. China reported impressive Advance 40 158 economy data and reduced trade war tension between US and China, Decline 10 41 boosted the global markets. India VIX slipped nearly 10%. Small-Cap Unchanged 0 2 Index rose close to 3%, followed by PSU Banks, Media, Auto and Metal stocks. Auto monthly sales for February was a mixed bag. Maruti and Top Nifty - 50 Index Gainers Ashok Leyland reported in-line Feb sales while Bajaj Auto announced lower than expected numbers. Escorts announced better-than- Scrip LTP % Change ZEEL 488 4.5 expected Feb sales. Bajaj Auto declined 1% to close at Rs2863, Maruti HINDPETRO 233 4.4 and Escorts gained 1% and 2% respectively. Tata Motors surged 2% to INDUSINDBK 1,517 2.9 close at Rs180 after the news that the company is likely to sell JLR BPCL 347 2.7 stake. -
Innovating with Infosys Finacle
PREFACE CUSTOMER CHANNEL/ PRODUCT SERVICE DISTRIBUTION INNOVATION INNOVATION INNOVATION INNOVATIVE INNOVATION CUSTOMS PROCESS IN PROJECT COMPONENT INNOVATION MANAGEMENT DEVELOPED Innovation continues to be the leitmotif of and felicitate our innovative partners. In this the global banking industry. A perfect storm booklet, I am proud to present the winners of of rising customer expectations, increasing the 2015 edition of the Infosys Finacle Client competitive pressures and stringent compliance Innovation Awards. demands is compelling more and more banks to In 2015, we received an overwhelming response pursue innovation for sustainable competitive in the form of 104 nominations across 6 advantage. innovation categories. Each nomination was Against this background, I am increasingly judged on the merits of the degree of innovation, enthused to see that many of our partners in the complexity of the initiative, and benefits financial services industry are leveraging Finacle delivered. Every nomination is an affirmation of solutions to develop deeper connections with how our clients are embracing breakthrough stakeholders, power continuous innovation, and innovations quickly to take advantage of global accelerate growth in the digital world. technology shifts and deliver differentiated products and services, based on their customers’ We instituted the Infosys Finacle Client unique requirements. Innovation Awards in 2014 to formally recognize 2 I External Document © 2016 EdgeVerve Systems Limited We found the entire process of inviting and -
Financial Performance of Indian Automobile Industry – with Special Reference to Selected Companies
Volume : 5 | Issue : 12 | December-2016 ISSN - 2250-1991 | IF : 5.215 | IC Value : 79.96 Original Research Paper Commerce Financial Performance of Indian Automobile Industry – with Special Reference to Selected Companies Research Scholar, Department of Commerce, Annamalai P.Manokaran University, Annamalai Nagar Tamilnadu Assistant Professor in Commerce, Department of Commerce, Dr.J.Paramasivam Annamalai University,Annamalai Nagar Tamilnadu The study was made with the objective to analyse financial performance of selected automobile companies in India. For this purpose the researcher selected six companies for the study period of ten years from 2005-06 to 2014-15 using Altman’s Z-score model. The study found that financial performance under Altman’s z-score model was good in case of Maruti Suzuki India Ltd., since calculated value of z-score was more than the standard norm during all the years of the study period. The calculated value of z-score of Mahindra and Mahindra Ltd. was more than the standard norm (2.99) during eight years and it was more than the standard norm during eight years in case of Bajaj Auto Ltd. and TVS Motor Company, since their ABSTRACT financial performance was satisfactory. Financial performance of Tata Motors Ltd. and Ashok Leyland Ltd., was good during four years, since their z-score was more than the standard norm during four years and during five years it was at grey zone and in one year it was poor. KEYWORDS financial performance, z-score, working capital, retained earnings and profit Introduction Methodology India is one of the fastest growing economies in the world. -
CIPLA, Ltd. CIPLA Ltd Is a Pharmaceutical Company Based in India
CIPLA Ltd. And the Provision of Anti-AIDS Pharmaceuticals It’s 2001, and G. G. Brereton is a busy man. He heads the Global Intellectual Property Office at GlaxoSmithKline (GSK), a multinational pharmaceutical corporation with operations throughout the world. He is tasked with defending GSK’s patents against foreign imitators. In recent months he has been occupied with infringements against GSK patents for antiretroviral drugs – the pharmaceuticals used to treat the symptoms of HIV and AIDS. This week has been especially hectic: CIPLA Ltd. of India has just announced its offer to supply an antiretroviral “cocktail” to Sub-Saharan African countries for 3 percent of the price that GSK charges for its anti-AIDS cocktail. Top management at GSK wants options for responding to this surprising offer. G. G. has been given the job of (1) coming up with potential responses by GSK to this initiative and (2) identifying that option that best assures the continued profitability of the firm now and into the foreseeable future. He has till Friday to do it! HIV/AIDS. One of the most vexing public-health problems of the new century has been the explosion in cases of human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS). In the year 2000, the United Nation AIDS Organization (UNAIDS) reported that 36.1 million people worldwide were living with HIV or AIDS. There were 5.3 million new cases of HIV infection in the year, and 3.0 million deaths attributable to HIV infection. Since its first diagnosis, the AIDS epidemic has claimed 21.8 million lives. -
A Comparative Study of Fundamental and Technical Analysis on Selected
World Wide Journal of Multidisciplinary Research and Development WWJMRD 2018; 4(6): 102-105 www.wwjmrd.com International Journal Peer Reviewed Journal A Comparative Study of Fundamental and Technical Refereed Journal Indexed Journal Analysis on Selected Automobile Companies In India Impact Factor MJIF: 4.25 E-ISSN: 2454-6615 Dr.S.Kamalasaravanan Dr.S.Kamalasaravanan Associate Professor, Department of Management Abstract Sciences,Hindusthan College of The Automotive industry in India is one of the largest in the world with an annual production of 23.96 Engineering and Technology, million vehicles in FY (fiscal year) 2016–17. The Government of India aims to make automobile Coimbatore, Tamilnadu, India. manufacturing the main driver of "Make in India" initiative, as it expects the passenger vehicles market to triple to 9.4 million units by 2026, as highlighted in the Auto Mission Plan (AMP) 2016-26. So, There is wide opportunities occurs in automobile industry in share market, this study is helpful to investors for safe invest money in selected shares. Keywords: Fundamental analysis, Technical analysis, Automobile industry India, investment decisions, Risk and Return Analysis 1. Introduction Nowadays, Security Analysis and Portfolio Management concern itself with investment in financial assets with specific attention to the returns and risk associated with investing in securities. Traditional investment analysis, when applied to securities, emphasizes the projection of prices and dividends. That is, the potential price of a firm’s common stock and the future dividend stream are forecasted, and then discounted back to the present. This intrinsic value is then compared with the security’s current market price. -
“Power Finance Corporation - Investors Interaction Meet”
“Power Finance Corporation - Investors Interaction Meet” May 31, 2018 MANAGEMENT: TEAM OF POWER FINANCE CORPORATION:- - Mr. Rajeev Sharma - Chairman and Managing Director - Mr. D. Ravi - Director (Commercial) - Mr. C. Gangopadhyay - Director (Project) - Shri Sitaram Pareek - Independent Director Page 1 of 23 Power Finance Corporation May 31, 2018 Speaker: Good Afternoon, Ladies and Gentlemen. On behalf of Power Finance Corporation, we feel honored and privileged to welcome you all to this Investors Interaction Meet. The company recently announced its financial results for the year 2017-18 and has been successful in maintaining its growth trajectory. PFC is always aiming to connect with its investor and build a strong and enduring positive relationship with the investment community. With this objective, today’s event has been organized to discuss PFC’s current performance and future outlook with the current and prospective investors. On the desk in the center is Chairman and Managing Director -- Shri Rajeev Sharma along with the other directors. To my immediate left is Shri DRavi – Director, Commercial. Next to him is Shri C Gangopadhyay – Director, Projects. To my extreme left is Shri Sitaram Pareek – Independent Director and beside him is Shri N.B. Gupta – Director, Finance. They are all in front of you to give a brief insight of PFC’s performance during the financial year 2017-18. They will also present to you a roadmap for the forthcoming year. I request Shri Rajeev Sharma -- Chairman and Managing Director to address the gathering. Rajeev Sharma: Thank you very much for sparing your valuable time to be present here during this interaction. -
Cipla Ltd (CIPLA)
Cipla Ltd (CIPLA) CMP: | 826 Target: | 975 (18%) Target Period: 12 months BUY January 30, 2021 Strong growth in India, RoW; better margins… Q3 revenues grew 18.2% YoY to | 5169 crore led by strong growth in domestic and RoW markets. Domestic sales grew 25.5% YoY to | 2231 crore. RoW markets business grew 47.2% YoY to | 823 whereas South Particulars Africa business fell 2.5% YoY to | 579 crore. US grew 9.6% YoY to | 1037 crore. EBITDA margins expanded 647 bps YoY to 23.8% mainly due to P articular Am ount significantly lower other expenditure. Hence, EBITDA grew 62.3% YoY to | Market Capitalisation | 66581 crore 1231 crore. PAT more than doubled to | 748 crore vs. | 351 crore in Q3FY20. Debt (FY20) | 2816 crore Cash (FY20) | 1004 crore Result Update Result Product launches, front-end shift key for formulation exports E V | 68393 crore 52 week H/L (|) 870/357 Formulation exports comprise ~54% of FY20 revenues. The company is E quity capital | 161.3 crore focusing on front-end model, especially for the US, along with a gradual shift from loss making HIV and other tenders to more lucrative respiratory and F ace value | 2 Price performance other opportunities in the US and EU. We expect export formulation sales to grow at 9.8% CAGR to | 12242 crore in FY20-23E. Key drivers will be a launch of inhalers (drug-device) and other products in developed markets. 1000 14000 12000 800 Indian formulations growth backed by new launches 10000 600 8000 With ~5% market share, Cipla is the third largest player in the domestic 400 6000 formulations market. -
S.NO. Contents Page No. 1. Introduction 1 2. Company Performance at a Glance 3 3. Vision and Core Values SWOT of Maruti Suzuki 5 4
S.NO. Contents Page No. 1. Introduction 1 2. Company Performance at a Glance 3 3. Vision and Core Values SWOT of Maruti Suzuki 5 4. Some Important Milestones 7 5. Current situation – Microenvironment 8 6. Current Marketing Practice 9 7. A brief overview of competition and Market 11 8. CDM Process for Cars in price range of 10-14 lacks 13 9. Market Segmentation 16 10. The Product 17 11. Pricing 18 12. Place 21 13. MUL financial stability 22 14. Communication strategy 23 15. Contingency Plan 24 16. Exhibit 1 26 17. Exhibit 2 30 18. Exhibit 3 36 19. Exhibit 4 37 1 1. I NTRODUCTION Maruti Suzuki India Ltd. – Company Profile Maruti Suzuki India Ltd. (current logo) Maruti Udyog Ltd. (old logo) Maruti Suzuki is one of the leading automobile manufacturers of India, and is the leader in the car segment both in terms of volume of vehicle sold and revenue earned. It was established in February, 1981 as Maruti Udyog Ltd. (MUL), but actual production started in 1983 with the Maruti 800 (based on the Suzuki Alto kei car of Japan), which was the only modern car available in India at that time. Previously, the Government of India held a 18.28% stake in the company, and 54.2% was held by Suzuki of Japan. However, in June 2003, the Government of India held an initial public offering of 25%. By May 10, 2007 sold off its complete share to Indian financial institutions. Through 2004, Maruti Suzuki has produced over 5 million cars. Now, the company annually exports more than 50,000 cars and has an extremely large domestic market in India selling over 730,000 cars annually. -
Information Nation
SPRING/SUMMER 2003 STERNbusiness InformationCrossing Nation Borders CEO Interviews: How UPS Delivers How Bic Stays on the Ball CreativeNiall Ferguson onThinking: Anglobalization India’s Software Giant EntrepreneurshipWhy Major Economies Don't in Move the in SyncDigitalUnderstanding Age New Consumer Markets Wal-Mart’s Foreign Travels Rx Coverage: Curing Telecom and Argentina a letter fro m the dean It’s more than fit- Metropolitan Opera, Munich’s Bayerische Staatsoper, ting that this issue and Milan’s La Scala. focuses on the topic Meeting in the heart of Europe, and with people of globalization and from different business cultures and scholarly crossing borders. In disciplines, added a great deal of context to all our recent months, Stern discussions. Of course, history is an important com- has seen significant ponent of context. Business history – long a strength milestones in our at Stern – has been augmented by the arrival in international efforts. This past January the inaugu- January of Professor Niall Ferguson, who recently ral, 28-person class of executive MBA students from joined us from Oxford University and is the author TRIUM, the program Stern offers jointly with the of the definitive two-volume history of the London School of Economics and the HEC School of Rothschild banking empire. His most recent book, Management in Paris, completed their studies. The Empire – which is partially excerpted in this issue – second TRIUM class, with 35 members, completed is a significant contribution to the growing literature its first module at our campus in New York that on globalization. same month. This innovative program, geared As several articles in this issue argue, toward inculcating a global perspective in its stu- understanding the historical development of dents, will continue throughout the year with international markets, companies, and financial sessions in Paris, London, Brazil, and Hong Kong.